BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/19/2016 2:49:00 PM | Browse: 401 | Download: 409
Publication Name World Journal of Gastroenterology
Manuscript ID 25150
Country/Territory United States
Received
2016-02-25 08:45
Peer-Review Started
2016-02-25 09:54
To Make the First Decision
2016-03-31 10:09
Return for Revision
2016-03-31 16:26
Revised
2016-04-08 06:40
Second Decision
2016-04-15 15:47
Accepted by Journal Editor-in-Chief
2016-04-17 17:51
Accepted by Company Editor-in-Chief
2016-04-20 14:09
Articles in Press
2016-04-20 14:09
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2016-05-05 16:41
Publish the Manuscript Online
2016-05-19 14:49
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title Current and emerging therapies in unresectable and recurrent gastric cancer
Manuscript Source Invited Manuscript
All Author List Erin Jou and Lakshmi Rajdev
Funding Agency and Grant Number
Corresponding author Lakshmi Rajdev, MD, Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, 1695 Eastchester Road, Bronx, NY 10467, United States. lrajdev@montefiore.org
Keywords Advanced gastric cancer; Immunotherapy; Human epidermal growth factor receptor type 2; Targeted therapy; Vascular endothelial growth factor receptor
Core Tip Despite many advances in medical and surgical treatments, gastric cancer remains the second leading cause of cancer deaths. There is a greater understanding of the molecular heterogeneity of gastric cancer in recent years, resulting in the development and clinical investigation of different targeted agents. This review will discuss current treatment strategies and highlight targeted therapies and emerging drugs for advanced gastric cancer.
Publish Date 2016-05-19 14:49
Citation Jou E, Rajdev L. Current and emerging therapies in unresectable and recurrent gastric cancer. World J Gastroenterol 2016; 22(20): 4812-4823
Url http://www.wjgnet.com/1007-9327/full/v22/i20/4812.htm
DOI http://dx.doi.org/10.3748/wjg.v22.i20.4812
Full Article (PDF) WJG-22-4812.pdf
Full Article (Word) WJG-22-4812.doc
Manuscript File 25150-Review.docx
Answering Reviewers 25150-Answering reviewers.pdf
Audio Core Tip 25150-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 25150-Conflict-of-interest statement.pdf
Copyright License Agreement 25150-Copyright assignment.PDF
Peer-review Report 25150-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 25150-Journal editor-in-chief review report.pdf
Scientific Misconduct Check 25150-Scientific misconduct check.pdf
Scientific Editor Work List 25150-Scientific editor work list.pdf